The impact of prescription depth, dose rate, plaque size, and source loading on the central axis using 103Pd, 125I, and 131Cs

Brachytherapy

Volumn 7, Issue 4, 2008, Pages 327-335

  Rivard, Mark J ^a   Melhus, Christopher S ^a   Sioshansi, Shirin ^a   Morr, Jody ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Brachytherapy; Brachytherapy dosimetry; Eye plaque; Ophthalmic applicator; Radionuclides

Indexed keywords

CESIUM 131; IODINE 125; PALLADIUM 103; RADIOISOTOPE; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL PROTOCOL; DOSE CALCULATION; DOSE RESPONSE; DOSIMETRY; EYE PLAQUE; LOW ENERGY RADIATION; PHOTON THERAPY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIOISOTOPE THERAPY; SCLERA DISEASE;

BRACHYTHERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; MELANOMA; MONTE CARLO METHOD; RADIOISOTOPES; SCLERA; UVEAL NEOPLASMS;

EID: 53349164256     PISSN: 15384721     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brachy.2008.05.002     Document Type: Article

References (36)

1. Nag S., Quivey J.M., Earle J.D., et al. The American Brachytherapy Society recommendations for brachytherapy of uveal melanomas. Int J Radiat Oncol Biol Phys 56 (2003) 544-555
2. Hawkins B.S., and Collaborative Ocular Melanoma Study Group. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large chorodial melanoma: IV. Ten-year mortality findings and prognostic factors. COMS Report Number 24. Am J Ophthalmol 138 (2004) 936-951
3. Damato B. Treatment of primary intraocular melanoma. Expert Rev Anticancer Ther 6 (2006) 493-506
4. Margo C.E. The Collaborative Ocular Melanoma Study: An overview. Cancer Control 11 (2004) 304-309
5. Finger P.T. Radiation therapy for choroidal melanoma. Surv Ophthalmol 42 (1997) 215-232
6. Bedford M.A., Bedotto C., and MacFaul P.A. Retinoblastoma: A study of 139 cases. Br J Ophthalmol 55 (1971) 19-27
7. 60 Co episcleral plaque therapy. Ophthalmology 96 (1989) 382-388
8. 106 Rh beta-ray applicators. Surv Ophthalmol 19 (1974) 85
9. 106Rh applicators of choroidal melanomas: Sixteen years' experience. In: Lommatzsch P.K., and Blodi F.C. (Eds). Intraocular tumors (1983), Academie-Verlag, Berlin 290-301
10. MacFaul P.A., and Morgan G. Histopathological changes in malignant melanomas of the choroid after cobalt plaque therapy. Br J Ophthalmol 61 (1977) 221-228
11. Markoe A.M., Brady L.W., Shields J.A., et al. Radioactive eye-plaque therapy versus enucleation for the treatment of posterior uveal malignant melanoma. Radiology 156 (1985) 801-803
12. Muller R.P., Busse H., Potter R., et al. Results of high dose 106-ruthenium irradiation of choroidal melanomas. Int J Radiat Oncol Biol Phys 12 (1986) 1749-1755
13. Packer S. Iodine-125 radiation of posterior uveal melanoma. Ophthalmology 94 (1987) 1621-1626
14. Stallard H.B. Radiobiology for malignant melanoma of the choroid. Br J Ophthalmol 50 (1966) 147-155
15. Fontanesi J., and Nag S. Brachytherapy for ocular disease. In: Nag S. (Ed). Principles and practice of brachytherapy (1997), Future Publishing Company Inc, Armonk, NY 291-304
16. Fontanesi J., and Meyer D. Treatment of large melanomas with split-plaque technique: Pilot experience. Endocuriether Hypertherm Oncol 11 (1995) 9-13
17. Rivard M.J., Coursey B.M., DeWerd L.A., et al. Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations. Med Phys 31 (2004) 633-674
18. Rivard M.J., Butler W.M., DeWerd L.A., et al. Supplement to the 2004 update of the AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations. Med Phys 34 (2007) 2187-2205
19. Finger P.T., Lu D., Buffa A., et al. Palladium-103 versus iodine-125 for ophthalmic plaque radiotherapy. Int J Radiat Oncol Biol Phys 27 (1993) 849-854
20. NUDAT 2.0, National Nuclear Data Center, Brookhaven National Laboratory. Available at: http://www.nndc.bnl.gov/nudat2/index.jsp. Accessed February 8, 2008.
21. 103Pd interstitial brachytherapy seed. Med Phys 29 (2002) 609-621
22. Taylor R.E.P., Yegin G., and Rogers D.W.O. Benchmarking BrachyDose: Voxel based EGSnrc Monte Carlo calculations of TG-43 dosimetry parameters. Med Phys 34 (2007) 445-457
23. 125I brachytherapy seed. Med Phys 33 (2006) 4675-4684
24. 131Cs source. Med Phys 34 (2007) 754-762
25. Wittman R.S., and Fisher D.R. Multiple-estimate Monte Carlo calculation of the dose rate constant for a cesium-131 interstitial brachytherapy seed. Med Phys 34 (2007) 49-54
26. Tailor RC, Ibbott GS, Lampe S, et al. Dosimetric characterization of a brachytherapy source by thermoluminescence dosimetry in liquid water. Med Phys 2008;35: In press.
27. Sou-Tung Chiu-Tsao. Personnel communication, 28 March 2007.
28. Astrahan M.A., Szechter A., and Finger P.T. Design and dosimetric considerations of a modified COMS plaque: The reusable "seed-guide" insert. Med Phys 32 (2005) 2706-2716
29. Astrahan M.A. Improved treatment planning for COMS eye plaques. Int J Radiat Oncol Biol Phys 61 (2005) 1227-1242
30. Freire J.E., Kolton M.M., Brady L.W., et al. Eye and orbit. In: Halperin E.C. (Ed). Perez and Brady's principles and practice of radiation oncology. 5th ed. (2008), Lippincott, Williams, & Wilkins, Philadelphia, PA 778-799
31. 106Ru plaques?. Int J Radiat Oncol Biol Phys 52 (2002) 1360-1366
32. 106Ru plaques for retinoblastoma. Int J Radiat Oncol Biol Phys 65 (2006) 1212-1221
33. 125I) plaque treatment of uveal melanoma. Int J Radiat Oncol Biol Phys 26 (1993) 613-618
34. Finger P.T., Berson A., Tracy N., et al. Palladium-103 plaque radiotherapy for choroidal melanoma: An 11 year study. Int J Radiat Oncol Biol Phys 54 (2002) 1438-1445
35. 125I seed (model 6711) in eye plaques. Med Phys 20 (1993) 383-389
36. Garcia Jr. J.P., Garcia P.T., Rosen R.B., et al. A 3-dimensional ultrasound C-scan imaging technique for optic nerve measurements. Ophthalmology 111 (2004) 1238-1243